semaglutide rybelsus Novo's gains FDA expansion to reduce risk of MACE like peptide Rybelsus 14mg Tablets | Semaglutide

Novo Nordisk filed an NDA for the CagriSema combination in December 2025, with an FDA decision anticipated in late 2026

Based on hazard ratios, this equates to roughly a 58% increased risk of developing all thyroid cancers and a 78% increased risk of developing medullary thyroid cancer compared to controls

10.2337/diabetes.51.5.1337 Diabetes 23 SamamaP.RumennikL.GrippoJ

We encourage individuals to schedule an appointment whenever theyre concerned about their digestive health

Consult your healthcare provider to ensure the safety and effectiveness of using both medications

However, this needle hasnt been used, so theres no risk of contamination and putting the cap right back on it is a safe way to hold it until youre ready to inject it